*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 14.45 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 63 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm in DRG | 4.9 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 5.56 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $715,612 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $2,045 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $11,359 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $4,074,534 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $64,675 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 33.33 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 417,755 | ||||
| Total Hospitalizations with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 25 | ||||
| DRG Share of Total Hospitalizations | 1.27 | ||||
| % of Total ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm in DRG | 1.94 | ||||
| Avg LOS at DRG | 3.9 | ||||
| Avg LOS with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 3.76 | ||||
| Readmission Rate at DRG | 16.53 | ||||
| Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Unplanned Readmission Rate at DRG | 11.52 | ||||
| Unplanned Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Total Medicare payments at DRG | $2,493,587,688 | ||||
| Total Medicare payments with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $135,220 | ||||
| Total Medicare payment per Day at DRG | $1,529 | ||||
| Total Medicare payment per Day with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $1,439 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,969 | ||||
| Total Medicare payment per Hospitalization with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $5,409 | ||||
| Total Medicare Charges at DRG | $11,318,800,289 | ||||
| Total Medicare Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $711,111 | ||||
| Avg Charges at DRG | $27,094 | ||||
| Avg Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $28,444 | ||||
| Mortality Rate at DRG | 0.87 | ||||
| Mortality Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 17.03 | ||||
| SNF Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Home Discharge Rate at DRG | 53.31 | ||||
| Home Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 68.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 20 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm in DRG | 1.55 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 5.7 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $176,328 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $1,547 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $8,816 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $880,233 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $44,012 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 60.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 292,335 | ||||
| Total Hospitalizations with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 14 | ||||
| DRG Share of Total Hospitalizations | 0.89 | ||||
| % of Total ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm in DRG | 1.09 | ||||
| Avg LOS at DRG | 2.96 | ||||
| Avg LOS with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 2.93 | ||||
| Readmission Rate at DRG | 19.18 | ||||
| Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Unplanned Readmission Rate at DRG | 13.96 | ||||
| Unplanned Readmission Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Total Medicare payments at DRG | $1,347,436,356 | ||||
| Total Medicare payments with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $61,111 | ||||
| Total Medicare payment per Day at DRG | $1,557 | ||||
| Total Medicare payment per Day with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $1,491 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,609 | ||||
| Total Medicare payment per Hospitalization with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $4,365 | ||||
| Total Medicare Charges at DRG | $7,385,462,160 | ||||
| Total Medicare Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $326,450 | ||||
| Avg Charges at DRG | $25,264 | ||||
| Avg Charges with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | $23,318 | ||||
| Mortality Rate at DRG | 0.57 | ||||
| Mortality Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 11.55 | ||||
| SNF Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | NA | ||||
| Home Discharge Rate at DRG | 63.79 | ||||
| Home Discharge Rate with ICD Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm | 92.86 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| AURORA ST. LUKE'S MEDICAL CENTER | 2900 W OKLAHOMA AVE | MILWAUKEE | WI | 53215 | 113 |
| HALIFAX REGIONAL MEDICAL CENTER | 250 SMITH CHURCH RD | ROANOKE RAPIDS | NC | 27870 | 57 |
| MEMORIAL HOSPITAL BELLEVILLE | 4500 MEMORIAL DR | BELLEVILLE | IL | 62226 | 52 |